Search results
Results from the WOW.Com Content Network
Signs and symptoms of anaphylaxis Hives on back. Acute soy allergy can have fast onset (from seconds to one hour) or slow onset (from hours to several days), depending on the conditions of exposure, [1] [3] whereas long-term soy allergy may begin in infancy with reaction to soy-based infant formula. [4]
The signs and symptoms of this disorder appear at an early age, generally childhood or adolescence. The causes of MERRF syndrome are difficult to determine, but because it is a mitochondrial disorder, it can be caused by the mutation of nuclear DNA or mitochondrial DNA . [ 3 ]
Pain and emotional symptom trajectories, on the other hand, displayed a variety of longitudinal patterns. The study concluded that while most patient's fibromyalgia symptoms endure, the severity of their pain tends to reduce over time. [235] Baseline depressive symptoms in adolescents appear to predict worse pain at follow-up periods. [236] [237]
Dr. Nipunie Rajapakse, a pediatric infectious diseases physician with the Mayo Clinic Children's Center, tells Yahoo Life that norovirus is unrelated to influenza, despite its nickname. Instead ...
Some people may also experience fatigue, low-grade fever, chills, headaches and muscle aches. It’s common for people to go from feeling well to suddenly having gastrointestinal symptoms. These ...
Peripheral neuropathy may be classified according to the number and distribution of nerves affected (mononeuropathy, mononeuritis multiplex, or polyneuropathy), the type of nerve fiber predominantly affected (motor, sensory, autonomic), or the process affecting the nerves; e.g., inflammation (), compression (compression neuropathy), chemotherapy (chemotherapy-induced peripheral neuropathy).
Familial Mediterranean fever (FMF) is a hereditary inflammatory disorder. [ 1 ] : 149 FMF is an autoinflammatory disease caused by mutations in the Mediterranean fever (MEFV) gene, which encodes a 781–amino acid protein called pyrin . [ 2 ]
There’s currently no approved vaccine for norovirus, although Moderna has begun a phase three trial in the U.S. for a vaccine using mRNA technology and aims to test it in 25,000 adults worldwide.